resiquimod has been researched along with Lung Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, FF; Hu, Y; Li, M; Liang, JY; Liu, L; Liu, YY; Wang, Y; Wu, JJ; Zhang, K; Zhang, YA | 1 |
| Bahmani, B; Bui, JD; DeTeresa, E; Fang, RH; Gao, W; Gong, H; Haushalter, KJ; Luk, BT; Previti, M; Zhang, J; Zhang, L; Zhou, J | 1 |
| Ahn, JS; Ahn, MJ; Ha, SJ; Heo, JY; Kim, JE; Kim, MS; Kim, S; Kim, SY; Koh, J; Ku, BM; Lee, KY; Lee, SH; Lee, SN; Lim, YT; Park, K; Park, YM; Sun, JM; Yang, S | 1 |
3 other study(ies) available for resiquimod and Lung Neoplasms
| Article | Year |
|---|---|
Human inflammatory dendritic cells in malignant pleural effusions induce Th1 cell differentiation.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Communication; Cell Differentiation; Dendritic Cells; Humans; Imidazoles; Lipopolysaccharides; Lung Neoplasms; Lymphocyte Activation; Macrophages; Phagocytosis; Pleural Effusion, Malignant; Primary Cell Culture; Th1 Cells; Toll-Like Receptors; Tumor Cells, Cultured | 2020 |
Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors.
Topics: Animals; Blood Platelets; Breast Neoplasms; Cell Line, Tumor; Cell Membrane; Cells, Cultured; Female; HT29 Cells; Humans; Imidazoles; Immunotherapy; Lung Neoplasms; Mice, Inbred C57BL; Nanoparticles; Neoplasms; Treatment Outcome; Tumor Microenvironment | 2021 |
Therapeutic efficacy of cancer vaccine adjuvanted with nanoemulsion loaded with TLR7/8 agonist in lung cancer model.
Topics: Adjuvants, Immunologic; Animals; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Emulsions; Humans; Imidazoles; Immune Checkpoint Inhibitors; Lung Neoplasms; Lymphocyte Activation; Mice; Programmed Cell Death 1 Receptor; Toll-Like Receptor 7; Toll-Like Receptor 8; Tumor Microenvironment | 2021 |